The challenge of methicillin resistant staphylococcal infection after total hip replacement: overlooked or

M C Parry1, C P Duncan1

  • 1University of British Columbia, Department of Orthopaedics, 3114-910 West 10th Avenue, Vancouver, British Columbia, Canada.

The Bone & Joint Journal
|November 9, 2014
PubMed

Insights

Prosthesis-preserving techniques are gaining traction for hip periprosthetic joint infections. This review examines evidence for treating infections caused by resistant bacteria, focusing on methicillin-resistant staphylococci.

Area of Science:

  • Orthopedic Surgery
  • Infectious Diseases
  • Microbiology

Background:

  • Periprosthetic joint infections (PJIs) of the hip pose significant challenges.
  • Increasing antimicrobial resistance in common pathogens complicates treatment.
  • Prosthesis-preserving strategies are being reconsidered.

Purpose of the Study:

  • To review current evidence on treating hip PJIs.
  • To focus on infections caused by resistant organisms, particularly methicillin-resistant staphylococci (MRSA).
  • To evaluate the efficacy of irrigation and debridement and one-stage revision for resistant PJIs.

Main Methods:

  • Literature review of studies on hip PJI treatment.
  • Analysis of evidence regarding irrigation and debridement and one-stage revision.
  • Focus on studies involving methicillin-resistant staphylococci.

Main Results:

  • Growing interest in prosthesis-preserving techniques for hip PJI.
  • Emergence of antimicrobial resistance in staphylococci impacting treatment options.
  • Advocacy for irrigation and debridement and one-stage revision in specific cases.

Conclusions:

  • Evidence supports exploring various treatment modalities for hip PJI.
  • Management of PJIs caused by resistant organisms requires careful consideration of available evidence.
  • Further research is needed to optimize outcomes for hip PJI, especially with resistant pathogens.

Related Concept Videos

Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
66
Staphylococcal Skin Infections01:29

Staphylococcal Skin Infections

Staphylococcus aureus is a Gram-positive coccus that resides harmlessly on the skin and mucous membranes of healthy individuals. When the skin barrier is breached, it can shift from a commensal to an opportunistic pathogen. This transition is facilitated by surface adhesins, such as clumping factor B and S. aureus surface protein G (SasG), which bind to structural proteins, including loricrin and cytokeratin, in the damaged epidermis. Protein A, another key factor, binds the Fc region of...
118
Mechanism of Antibiotic Resistance in MRSA01:25

Mechanism of Antibiotic Resistance in MRSA

Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and...
172
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
6.8K
Endocarditis III: Medical Management01:18

Endocarditis III: Medical Management

Infective endocarditis management involves a multifaceted approach encompassing infection prevention, lifestyle modifications, pharmacological therapy, and surgical management.Infection Prevention:Hand Hygiene: Thorough handwashing is crucial to prevent the spread of infection. Hand hygiene should be performed regularly, especially before and after using the restroom.Oral Hygiene: Good oral hygiene is essential. It includes brushing teeth immediately after waking up and before bed, flossing...
351
Endocarditis I: Introduction01:25

Endocarditis I: Introduction

Introduction:Endocarditis is the infection of the endocardium, the inner lining of the heart and its valves. When the heart muscle is involved, the condition is termed myocarditis, while an infection of the outer lining is called pericarditis. Infective endocarditis (IE) primarily affects the endocardium, where pathogens adhere to the valves or lining, forming vegetation that can lead to severe complications. Infective endocarditis occurs when microorganisms, usually bacteria from other body...
866